Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...
Le Lézard1d
Advarra Unveils Oncology Research Pulse
Advarra, the market leader in regulatory review solutions and clinical research technology, today announced the launch of Oncology Research Pulse, a new content-driven, thought leadership initiative ...
Le Lézard1d
ASPCA Sees Increase in Number of Calls to Poison Control Center in 2024, Including Rise in Cases Related to Hallucinogenic Mushroom Consumption
In recognition of Poison Prevention Week (March 16-22, 2025), the ASPCA® (The American Society for the Prevention of Cruelty to Animals®) is releasing its annual list of top pet toxins encountered by ...
Global Private Equity Deal Value Up Sequentially, Down YOY In February
Global private equity and venture capital deal value reached $37.93 billion in February, up 26.6% from January, according to ...
European Medical Journal2d
Nemolizumab in Moderate-to-Severe Atopic Dermatitis: Long-Term Safety and Efficacy and New Biomarker Insights
Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...
pharmaphorum3d
And then there were none: Regeneron cans last late-stage NGF drug
In its third-quarter results update, the company confirmed that it is halting further development of fasinumab, an NGF drug partnered with Teva and Mitsubishi Tanabe Pharma that was in phase 3 ...
pharmaphorum3d
AbbVie gets continuous Parkinson's drug over the line in US
It could face competition from other subcutaneous infusion therapies, notably Mitsubishi Tanabe Pharma's ND-0612 which is in late-stage clinical testing. Pfizer and Arvinas' much-anticipated oral ...
BMJ5d
Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction
YSa has received personal fees from Otsuka Pharmaceutical, Ono Pharmaceutical, Daiichi Sankyo, Mitsubishi Tanabe Pharma Corporation, AstraZeneca and Actelion Pharmaceuticals; and grants from Roche ...
MutualArt.com2d
Takao Tanabe
Heffel Fine Art Auction House hosted its highly-anticipated spring auction, showcasing more than 90 outstanding works of art to a packed sale room, buzzing with excitement. Works by Jean Paul Riopelle ...
Reuters1d
Health & Pharma News | Latest Healthcare Stories | Reuters
A view shows MMR vaccine at the City of Lubbock Health Department in Lubbock, Texas, U.S. February 27, 2025. Texas and New Mexico on Tuesday reported an increase of 28 cases of measles in the last ...
Bloomberg L.P.2d
Latest Sector News
Khosla Ventures founder Vinod Khosla discusses the role of artificial intelligence in the health care and energy with Caroline Hyde at the HumanX 2025 conference in Las Vegas. (Source: Bloomberg ...